User menu

EORTC LCCG Phase II study of topotecan in combination with cisplatin as second line chemotherapy of sensitive and refractory small cell lung cancer (SCLC)

Bibliographic reference Ardizzoni, A ; Manegold, C ; Debruyne, C ; Gaafar, R ; Buchholz, E ; et. al. EORTC LCCG Phase II study of topotecan in combination with cisplatin as second line chemotherapy of sensitive and refractory small cell lung cancer (SCLC). In: Lung Cancer, Vol. 29, no. suppl. 1, p. 51 (suppl. 2000)
Permanent URL http://hdl.handle.net/2078.1/117161